| Clinical Impact of the IBox As an Early Intervention TooL (NCT05112315) | Predict4Health | 2022-02-18 |
| Tacrolimus Exposure in Kidney Transplantation (NCT06348446) | Seoul National University Hospital | 2022-02-01 |
| TruGraf and TRAC In Pediatrics Study (NCT05335538) | Transplant Genomics, Inc. | 2021-11-30 |
| Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR (NCT04773392) | University of Southern California | 2021-11-23 |
| Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test (NCT04670926) | Transplant Genomics, Inc. | 2021-06-03 |
| Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection (NCT04727788) | Verici Dx | 2021-03-21 |
| Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients (NCT04817774) | Sangamo Therapeutics | 2021-03-17 |
| Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore (NCT04825262) | Singapore General Hospital | 2021-02-01 |
| An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR (NCT04711850) | Hansa Biopharma AB | 2021-01-20 |
| Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients (NCT04702022) | University of Liege | 2021-01-04 |
| Transition of Renal Patients Using AlloSure Into Community Kidney Care (NCT04601155) | CareDx | 2020-11-19 |
| Personalization of Immunosuppressive Treatment for Organ Transplant Recipients (NCT05747053) | George Washington University | 2020-10-01 |
| TruGraf® Long-term Clinical Outcomes Study (NCT04491552) | Transplant Genomics, Inc. | 2020-09-09 |
| Acceptability and Feasibility of TruGraf® Testing as Part of the Standard of Care (NCT04267016) | Transplant Genomics, Inc. | 2020-08-19 |
| The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma (NCT04657562) | National Science Centre, Poland | 2020-08-01 |
| Molecular Biomarkers in Renal Transplantation Via TruGraf® Test (NCT04398498) | Transplant Genomics, Inc. | 2020-04-13 |
| TruGraf® Testing in High-Risk Kidney Transplant Recipients (NCT04266613) | Transplant Genomics, Inc. | 2020-02-20 |
| Desensitization in Kidney Allograft Using Daratumumab (NCT04204980) | Assistance Publique - Hôpitaux de Paris | 2020-02-18 |
| Microbiome and Immunosuppression: The Mission Study (NCT04953715) | The University of Texas Medical Branch, Galveston | 2020-02-12 |
| Immune Monitoring to Facilitate Belatacept Monotherapy (NCT04177095) | Massachusetts General Hospital | 2020-02-11 |
| Protocol Biopsies in High-risk Renal Transplant Recipients (NCT04154267) | Hospital de Clinicas de Porto Alegre | 2020-02-01 |
| Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients (NCT04130685) | Rush University Medical Center | 2020-01-15 |
| Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients (NCT04225988) | Cedars-Sinai Medical Center | 2020-01-09 |
| Trifecta-Kidney cfDNA-MMDx Study (NCT04239703) | University of Alberta | 2019-12-01 |
| Immunosuppressant Medication Dosed Daily After Kidney Transplant (NCT04156204) | University of Colorado, Denver | 2019-11-20 |
| The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) (NCT04091984) | Natera, Inc. | 2019-11-06 |
| Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection (NCT04367610) | Istanbul University | 2019-09-01 |
| Transplant Antibody-Mediated Rejection: Guiding Effective Treatments (NCT03994783) | Imperial College London | 2019-07-17 |
| Cf-DNA Assay During Treatment of Acute Rejection (NCT04019353) | University of Minnesota | 2019-06-01 |
| An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients (NCT03897205) | Hansa Biopharma AB | 2019-04-30 |
| Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance (NCT04566055) | CareDx | 2019-03-01 |
| Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection (NCT03859388) | Cedars-Sinai Medical Center | 2019-03-01 |
| Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN (NCT03652402) | Assistance Publique - Hôpitaux de Paris | 2018-11-27 |
| Donor-specific Anti-HLA Antibodies Monitoring in Kidney Transplant Recipients (NCT03714113) | Medical University of Warsaw | 2018-10-01 |
| Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation (NCT03789006) | University of Khartoum | 2018-03-21 |
| Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants (NCT03363945) | Medeor Therapeutics, Inc. | 2018-03-15 |
| Expressive Writing in Kidney Transplant Patients (NCT04143178) | University of Roma La Sapienza | 2018-03-01 |
| Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant (NCT03380377) | Stanley Jordan, MD | 2018-02-21 |
| Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry (NCT03326076) | CareDx | 2018-01-23 |
| Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients (NCT03380936) | University of Colorado, Denver | 2018-01-17 |
| IL2 Imaging in Renal Transplantation (NCT03304223) | University Medical Center Groningen | 2017-12-01 |
| Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients (NCT03488771) | Clinical Hospital Merkur | 2017-03-05 |
| Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients (NCT03006419) | Coordinación de Investigación en Salud, Mexico | 2016-12-01 |
| The TOGETHER Project - Kidney RNA-seq Validation (NCT03874299) | Mayo Clinic | 2016-11-17 |
| Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation (NCT02974686) | Washington University School of Medicine | 2016-11-01 |
| The TOGETHER Project - Kidney (NCT03873623) | Mayo Clinic | 2016-11-01 |
| Development and Validation of a Comprehensive Classification Automation System for Kidney Allograft Biopsies (NCT05306795) | Paris Translational Research Center for Organ Transplantation | 2016-01-01 |
| The Efficacy of Plasmapheresis and Double Filtration Plasmapheresis (DFPP) in Kidney Transplant (NCT03965559) | Chiang Mai University | 2015-11-01 |
| Mesenchymal Stromal Cells in Kidney Transplant Recipients (NCT02012153) | Mario Negri Institute for Pharmacological Research | 2013-12-04 |
| Pediatric Induction Therapy in Kidney Transplantation (NCT06087003) | Gang Chen | 2013-03-03 |
| Australian Genomics Of Chronic Allograft Dysfunction Study (NCT06314230) | Western Sydney Local Health District | 2012-04-26 |
| Observational Cohort Study Renal Transplantation University Hospitals Leuven (NCT06505200) | Universitaire Ziekenhuizen KU Leuven | 2004-03-01 |